Background : High microsatellite instability (MSI-H) colorectal carcinomas (CRCs) with numerous mutations in the microsatellite sequence are characterized by a right-sided preponderance, frequent peritumoral and intratumoral lymphocytic infiltration, and frequent mucin production. However, no study has correlated anatomic site and type of genetic changes with clinicopathologic changes. Methods : We analyzed the histopathologic features of 135 MSI-H CRCs and compared them to 140 microsatellite stable (MSS) CRCs. Histopathologic changes in MSI-H were further analyzed according to anatomic sites and genetic changes. Results : MSI-H CRCs showed previously reported clinicopathologic findings; a right-sided preponderance, an increased number of mucinous carcinomas, and peritumoral lymphoid reactions (p<0.001 for each variable). Increased serum CEA levels showed an MSS CRC preponderance (p=0.013). We further analyzed the histologic differences between right-and left-sided MSI-H tumors. We found that MSI-H CRCs on both sides had similar clinicopathologic findings, except for higher tumor stage (p=0.048) and less frequent abnormal CEA levels in left-sided MSI-H tumors (p=0.027). We found that not all clinicopathologic features were different between hereditary nonpolyposis colorectal cancers (HNPCCs) and sporadic MSI-H CRCs. Conclusions : These findings indicate that MSI-H CRCs of the left colon have similar clinicopathologic characteristics as right-sided MSI-H CRCs. We did not find any significant clinicopathological difference between HNPCCs and sporadic MSI-H CRCs.
Colorectal carcinoma (CRC) is one of the most common tumors in Western countries and the fourth most common cancer in both genders in Korea (Korean Statistical Informative Service, 2005) . The molecular pathogenesis of CRC is well explained in 2 pathways: chromosomal instability (CIN) and microsatellite instability (MSI).
1,2 The MSI pathway begins with the inactivation of genes responsible for DNA nucleotide mismatch repair, which results in extensive mutations in DNA sequences with low frequencies of allelic losses and rare alterations of tumor DNA content. 3 After the discovery of MSI in cancer of the colon, 4 many studies of the genetic, pathologic, and clinical features of MSI colon cancer have been carried out. A National Cancer Institute (NCI) workshop suggested that the form of genomic instability associated with defective DNA mismatch repair in tumors should be called MSI and a panel of 5 microsatellites was validated by Ruschoff and Fishel. 5 The panel was composed of 2 mononucleotide repeats (bat26 and bat25) and 3 dinucleotide repeats (D5S346, D2S123, and D7S250). 6, 7 Tumors were divided into 3 groups according to 5 markers: high-frequency MSI (MSI-H, the majority of markers exhibit MSI); low-frequency MSI (MSI-L, only a minority of markers exhibit MSI); and a group lacking any apparent instability (MSS, none of the markers exhibit MSI). 5 Among these groups, MSI-H CRCs comprise 10-15% of sporadic CRCs and most of hereditary nonpolyposis colorectal cancers (HNPCCs).
5
MSI-H CRCs have characteristic clinical and pathological features compared to MSI-L and MSS CRCs such as enhanced survival, a marked preponderance of tumors proximal to the splenic flexure, earlier tumor stage, increased diploid status, poor differentiation, extracellular mucin production, a Crohn's-like lymphoid reaction, and a frequent relation to HNPCC.
8-10
Until recently, although many small-scale studies had been conducted to clarify the biologic nature of MSI-H CRCs, there were no reports correlating histological changes according to anatomic site and histological comparison with HNPCC-associated MSI-H tumors versus sporadic MSI-H tumors. In order to identify any clinicopathologic characteristics related to anatom-ic site and history of HNPCC, we analyzed the histopathologic features of 135 MSI-H CRCs and grouped and analyzed them according to anatomic site and type of genetic change.
MATERIALS AND METHODS

Case selection
A total of 135 MSI-H CRCs and 30 MSI-L CRCs from the 1,460 colon cancers that had been operated and diagnosed at Yonsei University Medical Center from 2003 to 2007 were included in this study. A total of 140 MSS CRCs that had been operated and diagnosed between May and October 2005 were used as controls. All cases had been confirmed by histological examination and molecular workup.
MSI analysis
DNA was extracted from formalin-fixed and paraffin-embedded tissue samples of 1,458 colon cancer cases. Tumor and adjacent normal areas were separately marked and collected for DNA extraction. The recommended panel (bat26, bat25, D5S346, D2S123, and D7S250) was used for genetic classification. PCR was done and differences in amplified PCR fragments between tumor and normal tissue were detected by gene analyzer. MSI-H tumors were defined as having instability in 2 or more markers (Fig. 1A) , MSI-L tumors as having instability in 1 marker (Fig. 1B) , and MSS tumors as showing no apparent instability (Fig. 1C) .
5 MSI-H CRCs accounted for 9.68% and MSI-L CRCs 2.05% of the 1,460 colorectal specimens that had been accumulated over the 5 years of the study (Table 1 ). This study was approved by the Institutional Review Board and informed consent from all participants was obtained.
Analysis of clinical features
Clinical variables such as sex, mortality, anatomic site, num- ber of tumors, stage, patient survival status, HNPCC association, and CEA level at diagnosis of CRC patients were obtained from medical records. The anatomic site of the tumor was classified as the ascending colon, transverse colon, descending colon, sigmoid colon, or rectum (Table 2 ) and divided into right and lest-side based on the location with regard to the splenic flexure. The number of tumor masses was determined according to endoscopic and gross findings. For diagnosis of HNPCC, we used the Amsterdam II criteria 11, 12 which were presented in 1999. Preoperative serum CEA levels for all patients were measured at the time of diagnosis (normal range: 0-5 ng/mL), and we divided CRCs into 2 groups; normal (range: 0-5.0 ng/mL) and abnormal (≥5.0 ng/mL).
Analysis of pathologic features
The clinicopathologic features of MSI-H and MSS CRCs were further analyzed according to site (right vs left) and history of HNPCC. The histological type of tumor was subclassified by mucinous carcinoma (carcinoma containing mucin over more than 50% of the tumor area), medullary carcinoma (poorly or undifferentiated carcinoma containing scant tumor stroma with intense peritumoral and intratumoral lymphocytic infiltration) and conventional adenocarcinomas.
13
Tumors were graded on the basis of glandular appearance and divided into well differentiated (glandular structures in more than 95% of the tumor), moderately differentiated (glandular structures in 50-95% of the tumor), and poorly differentiated lesions (glandular structures in less than 50% of the tumor). Lymphocytic reactions were estimated when there was more than a moderate degree of peritumoral or intratumoral lymphocytic infiltration and/or lymphoid follicle formation.
Extracellular mucin pool formation and tumor necrosis was rated as absent or present. The infiltrative tumor borders were classified as irregular or pushing types.
Statistical analysis
Statistical analysis of each parameter was performed to clarify associations between MSI-H and MSS CRCs using the 2 test for categorical variables and SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). All reported p-values are 2-sided and p-values of less than 0.05 were considered to indicate statistical significance.
RESULTS
Different in clinicopathlogic features between MSI-H CRCs and MSS CRCs
The clinicopathologic features of 135 MSI-H CRCs were compared to 140 MSS CRCs ( [67.1%] in right-sided MSI-H CRCs, p=0.061). No significant differences in sex, survival rate, histologic type and grade of tumor, peritumoral and intratumoral lymphocytic reaction, tumor necrosis, tumor border, association with HNPCC, and 5 molecular markers were found (p>0.05).
Comparison of clinicopathologic features between HNPCCs and sporadic MSI-H CRCs
The clinicopathologic features of MSI-H CRCs were compared to those of sporadic tumors and HNPCCs with HNPCC being defined as a positive result on the Amsterdam II criteria. We found that not all of the clinicopathologic features were different between CRCs from HNPCCs and sporadic MSI-H CRCs (Table 6 ). 
DISCUSSION
In this study, the clinicopathologic features of MSI-H CRCs were analyzed and compared to thosed of MSS CRCs. The incidence of MSI-H CRCs (9.25%) was slightly lower than the previously reported incidence of 12-15% in Western countries. 5 This difference might be due to the different preferred location of CRCs in Korean and Western populations. It is well known that the incidence of rectal cancer in the Korean population (58.0%) is higher than in Western populations (19.3%).
14,15 A very low incidence of MSI-H in rectal cancer has been reported, 5 and this was confirmed in our study (incidence of rectal cancer: 20/135 [14.8%] in MSI-H CRCs vs 73/140 [52.1%] in MSS CRCs, p<0.001). Therefore, the high preponderance of rectal cancer in the Korean population would explain a slightly lower incidence of MSI-H CRCs in our study.
5
Most of the clinicopathologic findings in our patients were in concordance with previously reported characteristics of MSI-H CRCs. Our MSI-H CRCs showed similarities to previously reported clinicopathologic findings in MSS carcinoma, p<0.001). Frequent intratumoral and peritumoral lymphoid reactions and mucin formation in MSI-H CRCs are related to the specific subtype of CRCs; medullary and mucinous carcinoma. We simplified the subclassification of histological type into medullary carcinoma, mucinous carcinoma, and other conventional adenocarcinomas, 13 and used this scheme to analyze clinicopathologic features. Medullary carcinomas were present in 11 of 135 (8.1%) MSI-H CRCs and mucinous carcinomas in 37 of 135 (27.4%) MSI-H CRCs. In contrast, no medullary carcinoma and 13 (9%) mucinous carcinomas were present in 140 MSS CRCs. These findings indicate that the histologic type of MSI-H CRCs is different from MSS CRCs, and is related to different biologic features.
CEA is a useful marker in screening for early disease, aiding diagnosis, determining prognosis, predicting likely responses to specific therapies, surveillance of patients undergoing curative resection, and monitoring the treatment of advanced disease. 16 18 However, they analyzed a smaller number of MSI-H CRCs, and both MSI-H and MSS CRCs showed higher CEA levels than our data did.
We classified tumor location as ascending colon, transverse colon, descending colon, sigmoid colon, and rectum, and tumor distribution was divided into right-and left-sided relative to the splenic flexure. We validated a right-sided preponderance of MSI-H CRCs that was statistically significant (p<0.001). We further analyzed the difference between right-and left-sided CRCs with MSI-H. There were no significant differences in sex, mortality, histological type and grade, peritumoral and intratumoral lymphocytic reaction, necrosis, tumor border, clinical history of HNPCC, and 5 molecular markers. HNPCC is a distinct autosomal dominant syndrome accounting for approximately 5-6% of the total colorectal cancer burden with clinical and pathologic features caused by defective mismatch repair genes. 11 We diagnosed HNPCC cased according to the Amsterdam II criteria and found 8 HNPCCs with MSI-H. It is well known that the majority of HNPCCs are located in the right colon. 5 In our study, among these 8 cases, 6 (75.0%) were located in the right colon. However, there was no statistical significance to the difference in tumor location between MSI-H CRCs associated with HNPCCs and sporadic MSI-H CRCs. Decreased preoperative serum levels of CEA in HNPCC have been reported. 19 However, our study found no significant difference in serum CEA level between HNPCC and sporadic MSI-H CRCs (p=0.635). Thus, we did not find any difference in clinicopathological characteristics between HNPCC-related MSI-H CRCs and sporadic MSI-H CRCs. These findings indicate that the molecular pathways involved in the pathogenesis of MSI-H tumors are similar although the initial inactivating mechanisms of mismatch repair genes are different.
CONCLUSIONS
We found that left-sided MSI-H CRCs were infrequent. However, they showed similar clinicopathological characteristics as right-sided MSI-H CRCs, except for less frequent-mucin formation, higher tumor stage and more frequent normal CEA levels. We could not find any significant clinicopathological differences between HNPCC-related MSI-H CRCs and sporadic MSI-H CRCs. These findings suggest that although the initial inactivating mechanisms of mismatch repair genes were different, the molecular pathways involved in the pathogenesis of MSI-H tumors are homogeneous, and show similar clinicopathological features.
